Anticoagulation

Hot Line Sessions Revealed for ESC Congress 2025

ESC Congress 2025 Scientific Programme

Elisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli, et al

Read time: 18m 58s

Ton Duy Mai, Tri Huynh Quang Ho, Sy Van Hoang, et al

Read time: 19m 6s
SCAI 25: Insights from the TRITAVI Registry

Francesco Pelliccia

Watch time: 11m 23s

Bianca Rocca, Hugo ten Cate

Read time: 17m 22s

Mahmoud Izraiq, Nail Alshoubaki, Omran A Abu-Dhaim, et al

Read time: 21s
ACC 25: Optimizing DAPT Duration

Hyo-Soo Kim

Watch time: 9m 39s
ACC 25: The SMART-CHOICE 3 Trial

Joo-Yong Hahn

Watch time: 4m 14s
ACC 25 Late-Breaking Discussion: The API-Cat Study

Harriette Van Spall, Isabelle Mahé

Watch time: 12m 9s
ACC 25: The Phase 3 REVERSE-IT Trial

Deepak L Bhatt

Watch time: 4m 15s

Monika Bhandari, Akshyaya Pradhan, Pravesh Vishwakarma, et al

Read time: 27m 35s
CRT 2025 Meeting Unveils its Late-Breaking Scientific Programme

CRT 2025

Darren Mylotte, Marie-Claude Morice, Roisin Colleran, et al

Watch time: 28m 31s (3 videos)

Sonika Malik, Anju Bhardwaj, Matthew Eisen, et al

Andreas Goette, Hein Heidbuchel

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Marco Valgimigli, Eliano Navarese, Pascal Vranckx

Watch time: 1h 48m 18s (11 videos)

Balen Abdulrahman, Richard J Jabbour, Nick Curzen

Read time: 18m
The Parallax Podcast

Ankur Kalra

Broadcast

Anticoagulation

Guidelines & Statements
What’s New in the European ACS Guidelines and How Will My Practice Change?

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Kerry Layne, Albert Ferro

Julia Sikorska, James Uprichard

Stuart J Head, Ad JJC Bogers, A Pieter Kappetein

Mario Petretta, Pierluigi Costanzo, Alberto Cuocolo

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Marco Valgimigli, Eliano Navarese, Pascal Vranckx

Watch time: 1h 48m 18s (11 videos)

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Media

Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Naveed Sattar, Philippe Gabriel Steg, Joshua Stolker, et al

Watch time: 35m 13s (4 videos)
BCIS ACI 2020: Update on DAPT

Robert F Storey

Watch time: 9m 41s
JIM 2020: Onyx ONE study

Gennaro Sardella

Watch time: 4m 25s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Tratamiento con ACOD en pacientes con FA post-ICP

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s
CRT 2020: Should we drop aspirin monotherapy?

Roxana Mehran

Watch time: 6m 21s
CRT 2020: Onyx One Global Study: MI predictors

Azeem Latib

Watch time: 6m 51s
CRT 2020: Duration of DAPT treatment in ST prevention

Dean J Kereiakes

Watch time: 11m 55s
CRT 2020: Anticoagulation vs antiplatelet therapy after TAVR

Toby Rogers

Watch time: 7m

Jan Steffel, Jur ten Berg, Stefan H Hohnloser

Watch time: 1h 4m 45s (3 videos)
PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 16m 18s
PART 3: Practical implementation and current guidelines

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 22m 30s
PART 2: Evolution of the data

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 25m 57s

Articles

Oral P2Y12 Inhibitors and Drug Interactions

Elisabetta Bigagli

,

Jacopo Angelini

,

Alessandro Mugelli

,

Bianca Rocca

,

Published:

11 June 2025

Citation:

European Cardiology Review 2025;20:e17.

DOI:

https://doi.org/10.15420/ecr.2025.12
Permissions× For commercial reprint enquiries please contact Springer Healthcare: [email protected].

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email [email protected].
  • Views: Views 668
  • Downloads: Downloads 76
  • Citations: 1
  • Read time: 18m 58s

Comparative Analysis of Direct Oral Anticoagulants in Atrial Fibrillation

Ton Duy Mai

,

Tri Huynh Quang Ho

,

Sy Van Hoang

,

Hoai Thi Thu Nguyen

,

Jeyaraj Pandian

,

Tan Van Nguyen

,

Khoa Tien Vu

,

Giang Song Tran

,

Viet Phuong Dao

,

Minh Cong Tran

,

Hung Manh Pham

,

Published:

09 May 2025

Citation:

European Cardiology Review 2025;20:e13.

DOI:

https://doi.org/10.15420/ecr.2025.07
Permissions× For commercial reprint enquiries please contact Springer Healthcare: [email protected].

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email [email protected].
  • Views: Views 4093
  • Downloads: Downloads 1361
  • Read time: 19m 6s

Factor XI Inhibition and AF

Bianca Rocca

,

Hugo ten Cate

,

Published:

10 April 2025

Citation:

European Cardiology Review 2025;20:e08.

DOI:

https://doi.org/10.15420/ecr.2024.61
Permissions× For commercial reprint enquiries please contact Springer Healthcare: [email protected].

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email [email protected].
  • Views: Views 632
  • Downloads: Downloads 60
  • Read time: 17m 22s

Corrigendum to: Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management

Mahmoud Izraiq

,

Nail Alshoubaki

,

Omran A Abu-Dhaim

,

Sarah Al-Qalalweh

,

Raed Aqel

,

Published:

02 April 2025

Citation:

Interventional Cardiology 2025;20:e12.

DOI:

https://doi.org/10.15420/icr.2024.25.co1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: [email protected].

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email [email protected].
  • Views: Views 303
  • Downloads: Downloads 41
  • Read time: 21s